Are there generic versions of bosutinib/bosutinib?

Bosutinib/Bosutinib is a targeted treatment drug for chronic myelogenous leukemia (CML) and is a tyrosine kinase inhibitor. This type of drug inhibits the activity of BCR-ABL fusion protein and prevents the proliferation of tumor cells, thereby achieving anti-cancer effects. Bosutinib is particularly suitable for patients with CML who have failed to respond to or developed resistance to previous treatments. The drug is administered orally, and the dosage needs to be adjusted according to the patient's specific conditions to achieve the best therapeutic effect.

The indications for bosutinib are mainly concentrated in adult patients with chronic myelogenous leukemia, especially those who have disease progression after at least first-line treatment. In addition, it is also being considered for use in patient groups where other targeted therapies have not responded well. Clinical studies have shown that bosutinib shows good efficacy in treating these refractory cases and is less likely to develop drug resistance, making it one of the important options for the treatment of CML. While taking bosutinib, patients may experience some common side effects, which are usually manageable, but in some cases may require dose adjustment or temporary discontinuation to ensure patient safety.

Regarding the generic drugs of bosutinib, there are currently many pharmaceutical companies producing related generic drugs in the international market, such as India's Mylan (Mylan), etc., and may have been sold in local hospitals or pharmacies. These generic drugs are basically the same as the original drugs in terms of drug ingredients, efficacy and specifications, but there may be differences in manufacturers and prices. Common specifications of bosutinib generic drugs include 400mg*30 tablets, 500mg*30 tablets and 100mg*120 tablets. Since the production cost of generic drugs is generally lower than that of original drugs, their prices are also significantly more affordable, usually priced at more than 1,000 yuan per box (prices may fluctuate due to exchange rates).

Reference materials:https://medlineplus.gov/druginfo/meds/a613005.html